Early Access — free while we kick the tires
EdgarHawk

Anderson Mark Guthrie

Director

Director
4 filings analyzed · 1 company · Latest 2025-06-02

Companies

Company Buys Sells Direction
Burke & Herbert Financial Services Corp. BHRB 6 0 Net buying

Activity

June 2025
Buy
2,000 shares
$112,798
Significance 5/10

Director Anderson Mark Guthrie bought 2,000 shares at blended avg $56.40; now holds 27.7K; stock -20.8% from 52-week high.

Anderson Mark Guthrie, a Director at BHRB, executed two separate purchases on June 2, 2025, totaling 2,000 shares for $112,798.05 at prices near the current market level ($56.28). His post-transaction holdings of 27.7K shares represent a +7.8% increase from his prior 25.7K-share position. The timing context is notable: the stock has declined 20.8% from its 52-week high of $71.04 and is down 8.2% over the past 90 days, yet this purchase comes as part of a cluster pattern with 2 other insiders buying within the past 14 days. At BHRB specifically, Guthrie's prior four completed trades (from Oct 2024 and Feb 2024) show a 0 of 3 well-timed 90-day outcome rate, with the Feb 2024 buy deteriorating to -10.5% by the 90-day mark. The company's fundamentals remain solid with net income of $27,201,000.00 and a P/E of 14.62, though the broader price momentum and Guthrie's historically inconsistent timing at this ticker warrant observation.

May 2025
Buy
2,300 shares
$131,667
Significance 5/10

Director Mark Guthrie buys 2,300 shares of BHRB at $57.25; stock now at $57.54, -19.0% from 52-week high

Anderson Mark Guthrie, a Director, purchased 2,300 shares at $57.25, increasing his holdings by 10.3% to 24,700 shares. This represents a second buy in three weeks (prior purchase on 2025-04-29), indicating continued accumulation at current valuation levels. The stock is currently trading near the transaction price ($57.54 vs. $57.25) but substantially below its 52-week high of $71.04, placing it -19.0% from peak. At BHRB specifically, Guthrie's prior four measurable trades show mixed outcomes—only 1 of 4 were well-timed at the 90-day mark—suggesting no clear pattern of prescient timing at this ticker. The company's P/E of 14.95 with $27.2M net income indicates a modestly-valued business, though recent price action (down 10.9% over 90 days, up 15.1% over 30 days) reflects volatility rather than a clear directional narrative.

April 2025
Buy
3,000 shares
$158,970
Significance 6/10

Director Anderson Mark Guthrie bought 3,000 shares at $52.99; 3 other insiders also bought within 14 days.

Anderson Mark Guthrie, a Director of Burke & Herbert Financial Services Corp., purchased 3,000 shares at $52.99, increasing his holdings to 22,400 shares. The transaction is noteworthy because it is part of a cluster: 3 other insiders also bought within the past 14 days, signaling coordinated internal confidence in the stock. At the current price of $55.57, the stock is -21.8% from its 52-week high of $71.04, and Guthrie's prior trades at BHRB show mixed timing results—1 of 4 prior buys achieved positive 90-day returns, suggesting only occasional alignment with favorable subsequent price movements. The company's P/E of 24.48 and net income of $27,622,000.00 provide a baseline for valuation context, though the cluster buying pattern warrants attention to whether insiders perceive undervaluation or are responding to other catalysts.

October 2024
Buy
1,200 shares
$77,035
Significance 5/10

Director Anderson Mark Guthrie buys 1,200 shares at $64.20 avg; holdings rise 6.6% to 19,400 shares

Anderson Mark Guthrie purchased 1,200 shares across two transactions at a blended average price of $64.20, increasing his holdings by 6.6% from 18,200 to 19,400 shares. The purchase occurred near the 52-week high ($68.72), with current price at $64.91 reflecting a -5.5% position relative to that peak. His same-ticker history shows mixed timing: a February 2024 buy declined 3.7% in 30 days and a September 2023 buy declined 5.3% in 30 days, though the latter recovered to +6.0% over 90 days. The company reports a negative net income of $-16,919,000.00 alongside a P/E of 21.28, creating a tension between the fundamental backdrop and this director-level accumulation. The transaction merits monitoring to assess whether this represents incremental conviction or routine portfolio activity in an operationally challenged context.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access